The Defense Health Agency awarded a $557,592 Project Grant to Northwestern University in Evanston, Illinois under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "OVERCOMING RESISTANCE IN SYNOVIAL SARCOMA TO INTERFERON GAMMA-MEDIATED IMMUNOSENSITIZATION," will fund research to address resistance in synovial sarcoma to interferon gamma-mediated immunosensitization. The award period runs from November 1, 2024 to October 31, 2027. As a leading academic research institution, Northwestern University has extensive experience conducting innovative biomedical research and collaborating with federal agencies through grant and contract awards to advance scientific knowledge and develop new medical solutions.
Generated 3/4/25, 5:51 AM